litlas
Log inCreate account

Eberhard Ritz

Active 1973–2019

196
Papers
48,858
Citations
117
h-index
196
i10-index

Citations

Citations per year for Eberhard Ritz1975: 1 citations1976: 5 citations1977: 4 citations1978: 7 citations1979: 3 citations1980: 4 citations1981: 3 citations1982: 5 citations1983: 5 citations1984: 2 citations1985: 12 citations1986: 6 citations1987: 22 citations1988: 20 citations1989: 25 citations1990: 25 citations1991: 27 citations1992: 41 citations1993: 42 citations1994: 39 citations1995: 53 citations1996: 63 citations1997: 107 citations1998: 119 citations1999: 172 citations2000: 207 citations2001: 231 citations2002: 296 citations2003: 456 citations2004: 449 citations2005: 494 citations2006: 450 citations2007: 401 citations2008: 411 citations2009: 391 citations2010: 403 citations2011: 472 citations2012: 434 citations2013: 392 citations2014: 354 citations2015: 272 citations2016: 250 citations2017: 238 citations2018: 213 citations2019: 763 citations2020: 708 citations2021: 623 citations2022: 442 citations2023: 312 citations2024: 493 citations2025: 191 citations2026: 7 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,771 citing papers, 25.6% of this breakdownGermany: 1,060 citing papers, 7.2% of this breakdownUnited Kingdom: 1,026 citing papers, 6.9% of this breakdownItaly: 811 citing papers, 5.5% of this breakdownChina: 761 citing papers, 5.2% of this breakdownCanada: 611 citing papers, 4.1% of this breakdownAustralia: 601 citing papers, 4.1% of this breakdownJapan: 588 citing papers, 4% of this breakdownNetherlands: 575 citing papers, 3.9% of this breakdownFrance: 530 citing papers, 3.6% of this breakdownSpain: 389 citing papers, 2.6% of this breakdownSweden: 284 citing papers, 1.9% of this breakdown
0%25.6%Other 25.4%

Institutions

Fields

  • Medicine82.8%
  • Biochemistry, Genetics and Molecular Biology10.4%
  • Immunology and Microbiology1.5%
  • Nursing1.3%
  • Health Professions0.8%
  • Neuroscience0.7%
  • Other2.5%

Topics

  • Chronic Kidney Disease and Diabetes8.4%
  • Dialysis and Renal Disease Management5.8%
  • Blood Pressure and Hypertension Studies4.1%
  • Parathyroid Disorders and Treatments3.4%
  • Vitamin D Research Studies2.7%
  • Diabetes Treatment and Management2.7%
  • Other72.9%

Coauthors

All papers

Open in search
  1. Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

    Authors: Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke, Tomás Berl, Marc A. Pohl, Julia B. Lewis, Eberhard Ritz, Robert C. Atkins, Richard Rohde, Itamar Raz - New England Journal of Medicine 2001 cited by 6,001

  2. Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis

    Authors: Christoph Wanner, Vera Krane, Winfried März, Manfred Olschewski, Johannes F.E. Mann, G. Ruf, Eberhard Ritz - New England Journal of Medicine 2005 cited by 2,607

  3. Essential hypertension

    Authors: Franz H. Messerli, Bryan Williams, Eberhard Ritz - The Lancet 2007 cited by 681

  4. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

    Authors: Charles A. Herzog, Richard Asinger, Alan K. Berger, David M. Charytan, Javier Dı́ez, Robert G. Hart, Kai‐Uwe Eckardt, Bertram L. Kasiske, Peter A. McCullough, Rod Passman, Stephanie DeLoach, Patrick H. Pun, Eberhard Ritz - Kidney International 2011 cited by 925

  5. Uric Acid and Cardiovascular Events

    Authors: Marcus E. Kleber, Graciela Delgado, Tanja B. Grammer, Günther Silbernagel, Jie Huang, Bernhard K. Krämer, Eberhard Ritz, Winfried März - Journal of the American Society of Nephrology 2015 cited by 298

  6. Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD

    Authors: Gerald Schulman, Tomás Berl, Gerald J. Beck, Giuseppe Remuzzi, Eberhard Ritz, Kiyoshi Arita, Akira Kato, Miho Shimizu - Journal of the American Society of Nephrology 2014 cited by 269

  7. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions

    Authors: Eberhard Ritz, Ivan Rychlík, Francesco Locatelli, Serge Halimi - American Journal of Kidney Diseases 1999 cited by 803

  8. Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

    Authors: Hermann Haller, Sadayoshi Ito, Joseph L. Izzo, Andrzej Januszewicz, Shigehiro Katayama, Jan Menne, A Mimran, Ton J. Rabelink, Eberhard Ritz, Luís M. Ruilope, Lars Christian Rump, Giancarlo Viberti - New England Journal of Medicine 2011 cited by 791

  9. Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency

    Authors: Giuseppe Maschio, Daniele Alberti, G. Janin, Francesco Locatelli, Johannes F.E. Mann, M Motolese, Claudio Ponticelli, Eberhard Ritz, P Zucchelli - New England Journal of Medicine 1996 cited by 1,772

  10. Nephron Number in Patients with Primary Hypertension

    Authors: Gunhild Keller, Gisela Zimmer, Gerhard Mall, Eberhard Ritz, Kerstin Amann - New England Journal of Medicine 2003 cited by 1,102

  11. The Heidelberg classification of renal cell tumours

    Authors: Gyula Kovács, Mohammed Akhtar, Bruce Beckwith, Peter Bugert, Colin S. Cooper, Brett Delahunt, John N. Eble, Stewart Fleming, Börje Ljungberg, L. Jeffrey Medeiros, H. Moch, Victor E. Reuter, Eberhard Ritz, Göran Roos, Dietmar Schmidt, John R. Srigley, Stephan Störkel, Eva Van Den Berg, Bert Zbar - The Journal of Pathology 1997 cited by 1,322

  12. Combining GFR and Albuminuria to Classify CKD Improves Prediction of ESRD

    Authors: Stein Hallan, Eberhard Ritz, Stian Lydersen, Solfrid Romundstad, Kurt Kvenild, Stephan R. Orth - Journal of the American Society of Nephrology 2009 cited by 444

  13. Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers

    Authors: Hiddo J.L. Heerspink, Frank A. Holtkamp, Hans‐Henrik Parving, Gerjan Navis, Julia B. Lewis, Eberhard Ritz, Pieter A. de Graeff, Dick de Zeeuw - Kidney International 2012 cited by 251

  14. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure

    Authors: Ute I. Schwarz, Moriz Buzello, Eberhard Ritz, Günter Stein, G Raabe, Gabriele Wiest, Gerhard Mall, Kerstin Amann - Nephrology Dialysis Transplantation 2000 cited by 625

  15. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease

    Authors: Danilo Fliser, Giovanni Pacini, R. Engelleiter, Alexandra Kautzky‐Willer, Rudolf Prager, Edward Franek, Eberhard Ritz - Kidney International 1998 cited by 359

  16. Lipoprotein(a) Serum Concentrations and Apolipoprotein(a) Phenotypes in Mild and Moderate Renal Failure

    Authors: Florian Kronenberg, Erich Kuen, Eberhard Ritz, Ralf Junker, PAUL KO[Combining Diaeresis]NIG, GU[Combining Diaeresis]NTER KRAATZ, Karl Lhotta, Johannes F.E. Mann, GERHARD A. MUCombining DiaeresisLLER, Ulrich Neyer, Werner Riegel, Peter Riegler, Vedat Schwenger, Arnold von Eckardstein - Journal of the American Society of Nephrology 2000 cited by 243

  17. The double challenge of resistant hypertension and chronic kidney disease

    Authors: Patrick Rossignol, Ziad Massy, Michel Azizi, George L. Bakris, Eberhard Ritz, Adrian Covic, David Goldsmith, Gunnar H. Heine, Kitty J. Jager, Mehmet Kanbay, Francesca Mallamaci, Alberto Ortíz, Raymond Vanholder, Andrzej Więcek, Carmine Zoccali, Gérard M. London, Bénédicte Stengel, Denis Fouque - The Lancet 2015 cited by 184

  18. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study

    Authors: Gisela Sturm, Barbara Kollerits, Ulrich Neyer, Eberhard Ritz, Florian Kronenberg - Experimental Gerontology 2008 cited by 169

  19. Nephropathy in Patients with Type 2 Diabetes Mellitus

    Authors: Eberhard Ritz, Stephan R. Orth - New England Journal of Medicine 1999 cited by 762

  20. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

    Authors: Dick de Zeeuw, Rajiv Agarwal, Michael Amdahl, Paul Audhya, Daniel W. Coyne, Τushar Garimella, Hans‐Henrik Parving, Yili Pritchett, Giuseppe Remuzzi, Eberhard Ritz, Dennis L. Andress - The Lancet 2010 cited by 690

  21. Avosentan Reduces Albumin Excretion in Diabetics with Macroalbuminuria

    Authors: R WENZEL, T. Littke, Susan Kuranoff, Christiane Ju[Combining Diaeresis]rgens, Heike Bruck, Eberhard Ritz, Thomas Philipp, Anna Mitchell - Journal of the American Society of Nephrology 2009 cited by 245

  22. Independent and Additive Impact of Blood Pressure Control and Angiotensin II Receptor Blockade on Renal Outcomes in the Irbesartan Diabetic Nephropathy Trial

    Authors: Marc A. Pohl, Samuel S. Blumenthal, D Cordonnier, Fernando de Álvaro, Giacomo Deferrari, Gilbert M. Eisner, Enric Esmatjes, Richard E. Gilbert, Lawrence G. Hunsicker, José B. Lopes de Faria, Ruggero Mangili, Jack Moore, Efrain Reisin, Eberhard Ritz, Guntram Schernthaner, Samuel Spitalewitz, H Tindall, Roger A. Rodby, Edmund J. Lewis - Journal of the American Society of Nephrology 2005 cited by 374

  23. Randomized Controlled Trial on the Efficacy and Safety of Atorvastatin in Patients with Type 2 Diabetes on Hemodialysis (4D Study): Demographic and Baseline Characteristics

    Authors: Christoph Wanner, Vera Krane, Winfried März, Manfred Olschewski, Hans-Gernot Asmus, Walter Krämer, Karlwilhelm Kühn, Heinrich Kütemeyer, Johannes F.E. Mann, G. Ruf, Eberhard Ritz - Kidney & Blood Pressure Research 2004 cited by 159

  24. Vitamin D, cardiovascular disease and mortality

    Authors: Stefan Pilz, Andreas Tomaschitz, Winfried März, Christiane Drechsler, Eberhard Ritz, Armin Zittermann, Etienne Cavalier, Thomas R. Pieber, Joan M. Lappe, William B. Grant, Michael F. Holick, Joost Dekker - Clinical Endocrinology 2011 cited by 259